VRCA- Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc. (VRCA) has 5 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. VRCA is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.96M | $21.22M | - | |
| CEO | 182.6K | $978.7K | - | |
| COO | 21.0K | $112.6K | - | |
| CFO | 19.0K | $101.6K | - | |
| Other | 2.4K | $12.6K | - |
Activity
Buys and sells only
Transactions
10 filings · page 4
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2023 | White Ted81 | President And CEO | Sell | 50,677 | $4.83 | $244,769.91 | -28.2% | -30.7% | +46.8% | |
| Jul 11, 2022 | Hayes Christopher G.70 | Chief Legal Officer | Buy | 7,500 | $3.40 | $25,500.00 | +91.3% | -18.0% | +135.4% | |
| Jul 5, 2022 | Perceptive Advisors LLC51 | 10% Owner | Buy | 1,428,571 | $2.10 | $2,999,999.10 | +39.6% | +19.6% | +136.8% | |
| Jul 5, 2022 | Hayes Christopher G.70 | Chief Legal Officer | Buy | 5,714 | $2.10 | $11,999.40 | +228.6% | +19.6% | +136.8% | |
| Jul 5, 2022 | White Ted81 | President And CEO | Buy | 23,809 | $2.10 | $49,998.90 | +420.9% | +19.6% | +136.8% | |
| Jul 5, 2022 | Goldenberg Gary83 | Chief Medical Officer | Buy | 23,809 | $2.10 | $49,998.90 | New | +19.6% | +136.8% | |
| Jul 5, 2022 | Stalfort John A III | Director | Buy | 238,095 | $2.10 | $499,999.50 | +51.5% | +19.6% | +136.8% | |
| Jul 5, 2022 | Manning Paul B54 | Director, 10% Owner | Buy | 4,761,904 | $2.10 | $9,999,998.40 | +53.6% | +19.6% | +136.8% | |
| Dec 3, 2021 | Manning Paul B54 | Director, 10% Owner | Buy | 50,000 | $9.36 | $467,905.29 | +0.3% | -9.0% | -63.7% | |
| Jun 4, 2021 | White Ted81 | President And CEO | Buy | 4,000 | $9.95 | $39,800.00 | +22.3% | +25.1% | -76.8% |